JPMorgan Claverhouse Inv Trust (JCH)

Sector:

Investment Firms

Index:

FTSE Small Cap

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

678.00p
   
  • Change Today:
      2.00p
  • 52 Week High: 766.00
  • 52 Week Low: 648.00
  • Currency: UK Pounds
  • Shares Issued: 56.39m
  • Volume: 83,065
  • Market Cap: £382.33m
  • RiskGrade: 79
  • Beta: 0.01

Hikma Pharmaceuticals non-exec sells 5,700 shares

Date: Tuesday 21 May 2013

LONDON (ShareCast) - Ronald Goode, a non-Executive Director of Hikma Pharmaceuticals, has disposed of 5,700 shares at 983.00p each.

The £56,031 sale comes less than a week after the company upgraded its 2013 revenue growth forecast following a strong start to the year.

In an announcment released May 16th, the group told investors it expects revenue to rise 13% this year, up from its previous guidance of 10%, driven by the performance of Branded and Injectables and Generics businesses in the year-to-date.

The Branded and Injectables unit is on track to meet the firm’s full-year guidance, while the Generics arm is continuing to benefit from its doxycycline product which is delivering revenue ahead of forecasts.

Branded revenue is expected to increase 11% in 2013, with a slight improvement in adjusted operating margin.

Goode now owns 17,000 shares.


Top Director Buys

Symphony International Holdings Ltd. (SIHL)
Amount purchased: 500,000 @ $0.78
Director name: Mr Anil Thadani
Value: $388,750

Symphony International Holdings Ltd. (SIHL)
Director name: Mr Anil Thadani
Amount purchased: 30,000 @ $0.76
Value: $22,800

Xchanging (XCH)
Director name: Mr Bill Thomas
Amount purchased: 14,289 @ 139.97p
Value: £20,000

Zotefoams (ZTF)
Director name: Ms Marie-Louise Clayton
Amount purchased: 8,000 @ 195.00p
Value: £15,600

JPMorgan Overseas Inv Trust (JMO)
Director name: Mr Jonathan Carey
Amount purchased: 1,500 @ 923.00p
Value: £13,845

JPMorgan Claverhouse Inv Trust (JCH)
Director name: Mr Andrew L Sutch
Amount purchased: 2,196 @ 521.39p
Value: £11,450


Top Director Sells

Sirius Minerals (SXX)
Director name: Mr Jason Murray
Amount sold: 2,166,667 @ 23.00p
Value: £498,333

Spectris (SXS)
Director name: Mr James Webster
Amount sold: 19,821 @ 2,129.31p
Value: £422,051

Hikma Pharmaceuticals (HIK)
Director name: Dr Ronald Goode
Amount sold: 5,700 @ 983.00p
Value: £56,031

NR

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

JCH Market Data

Currency UK Pounds
Share Price 678.00p
Change Today 2.00p
% Change 0.30 %
52 Week High 766.00
52 Week Low 648.00
Volume 83,065
Shares Issued 56.39m
Market Cap £382.33m
Beta 0.01
RiskGrade 79

JCH Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
57.5% below the market average57.5% below the market average57.5% below the market average57.5% below the market average57.5% below the market average
42.18% below the sector average42.18% below the sector average42.18% below the sector average42.18% below the sector average42.18% below the sector average
Price Trend
4.23% above the market average4.23% above the market average4.23% above the market average4.23% above the market average4.23% above the market average
40.8% below the sector average40.8% below the sector average40.8% below the sector average40.8% below the sector average40.8% below the sector average
Income
7.89% below the market average7.89% below the market average7.89% below the market average7.89% below the market average7.89% below the market average
63.22% above the sector average63.22% above the sector average63.22% above the sector average63.22% above the sector average63.22% above the sector average
Growth
36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average
17.06% below the sector average17.06% below the sector average17.06% below the sector average17.06% below the sector average17.06% below the sector average

JCH Dividends

  Latest Previous
  Q2 Q1
Ex-Div 08-Aug-19 02-May-19
Paid 02-Sep-19 31-May-19
Amount 6.25p 6.25p

Trades for 21-Aug-2019

Time Volume / Share Price
16:35 7,500 @ 678.00p
16:35 7,606 @ 678.00p
16:12 22 @ 676.50p
14:04 29,592 @ 674.00p
15:59 9,500 @ 678.00p

JCH Key Personnel

Chair Andrew L Sutch

Top of Page